标题
An easy pill to swallow: oral recombinant vaccines for the 21st century
作者
关键词
-
出版物
CURRENT OPINION IN IMMUNOLOGY
Volume 84, Issue -, Pages 102374
出版商
Elsevier BV
发表日期
2023-08-09
DOI
10.1016/j.coi.2023.102374
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2
- (2023) Molly R. Braun et al. Frontiers in Immunology
- Six places where drones are delivering medicines
- (2022) Elizabeth Snouffer NATURE MEDICINE
- Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
- (2022) Stephanie N. Langel et al. Science Translational Medicine
- Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens
- (2022) Becca A. Flitter et al. Vaccines
- SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
- (2022) Brian J. Willett et al. Nature Microbiology
- Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
- (2022) Sebastian Havervall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
- (2022) Meera Madhavan et al. EBioMedicine
- Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
- (2022) Ryuta Uraki et al. LANCET INFECTIOUS DISEASES
- Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
- (2022) Chaitanya Kurhade et al. NATURE MEDICINE
- How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low- and middle-income countries (LMICs): A scoping review of the literature
- (2021) Ibrahim K Dadari et al. Journal of Global Health
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Human influenza virus challenge identifies cellular correlates of protection for oral vaccination
- (2021) David R. McIlwain et al. Cell Host & Microbe
- Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model
- (2021) Susan Johnson et al. JOURNAL OF INFECTIOUS DISEASES
- Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
- (2021) Lin Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
- (2020) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
- (2019) Shinji Saito et al. PLoS Pathogens
- An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling
- (2019) Emery G. Dora et al. VACCINE
- Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development
- (2019) Roberto Mateo et al. JOURNAL OF INFECTIOUS DISEASES
- Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats
- (2018) Christina Joyce et al. VACCINE
- Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults
- (2016) Wilfredo R. Matias et al. PLoS Neglected Tropical Diseases
- Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
- (2016) Sasirekha Ramani et al. PLoS Pathogens
- Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus
- (2016) Ayan Dey et al. PLoS One
- Global Economic Burden of Norovirus Gastroenteritis
- (2016) Sarah M. Bartsch et al. PLoS One
- High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
- (2015) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Comparison of Antiviral Activity between IgA and IgG Specific to Influenza Virus Hemagglutinin: Increased Potential of IgA for Heterosubtypic Immunity
- (2014) Mieko Muramatsu et al. PLoS One
- Recombinant IgA Is Sufficient To Prevent Influenza Virus Transmission in Guinea Pigs
- (2013) C. W. Seibert et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
- (2013) Marc Gurwith et al. LANCET INFECTIOUS DISEASES
- An Adenovirus-Based Vaccine with a Double-Stranded RNA Adjuvant Protects Mice and Ferrets against H5N1 Avian Influenza in Oral Delivery Models
- (2012) Ciaran D. Scallan et al. Clinical and Vaccine Immunology
- Human Plasma-derived Polymeric IgA and IgM Antibodies Associate with Secretory Component to Yield Biologically Active Secretory-like Antibodies
- (2012) Stéphanie Longet et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
- (2012) Christopher S. Ambrose et al. VACCINE
- The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses
- (2008) Alexandra Bonner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now